226 results on '"Al Ejeh, Fares"'
Search Results
2. Contributors
3. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.
4. Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer
5. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
6. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
7. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
8. Cancer Incidence and Mortality Estimates in Arab Countries in 2018: a GLOBOCAN Data Analysis
9. Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2.
10. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis
11. Molecular Diagnostics: Translation from Discovery to Clinical Practice
12. Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress
13. Supplementary Figure 1 from Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma
14. Supplementary Methods from Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma
15. Supplementary Figure 4 from Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma
16. Supplementary Figure 2 from Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma
17. Supplementary Tables from G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
18. Supplementary Figure 3 from Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma
19. Supplementary Figures from G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
20. Supplementary Figures S1-S12 from Nutlin-3a Is a Potential Therapeutic for Ewing Sarcoma
21. Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells
22. Cancer incidence and mortality estimates in Arab countries in 2018: A GLOBOCAN data analysis
23. Multidimensional phenotyping of breast cancer cell lines to guide preclinical research
24. Chapter 4 - Proteomic understanding of SARS-CoV-2 infection and COVID-19: Biological, diagnostic, and therapeutic perspectives
25. EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
26. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance
27. Referee report. For: XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer [version 3; peer review: 2 approved]
28. Referee report. For: XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer [version 2; peer review: 1 approved, 1 approved with reservations]
29. Epigenome erosion drives neural crest-like phenotypic mimicry in triple-negative breast cancer and other SOX10+ malignancies
30. A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer
31. Robust prognostic signatures derived from proteomic panel profiling of plasma from patients with severe COVID-19 complications
32. G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
33. Tocotrienol as a potential anticancer agent
34. Differential gene expression of tumor-infiltrating CD8+T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis
35. Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases
36. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome
37. Differential gene expression of tumor-infiltrating CD4+ T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis
38. Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell lines
39. LobSig, a prognostic signature for ILC
40. Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment
41. Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer
42. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
43. EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma
44. Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study
45. Quinazolinone derivatives as inhibitors of homologous recombinase RAD51
46. Clinicopathologic significance of nuclear HER4 and phospho-YAP(S 127) in human breast cancers and matching brain metastases.
47. Differential gene expression of tumor-infiltrating CD4+ T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis.
48. Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient
49. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma
50. Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.